The emergence and global spread of SARS-CoV-2 has resulted in the urgent need for an in-depth
understanding of molecular functions of viral proteins and their interactions with the …

The severe‐acute‐respiratory‐syndrome‐coronavirus‐2 (SARS‐CoV‐2) is the causative
agent of COVID‐19, but host cell factors contributing to COVID‐19 pathogenesis remain only …

As the COVID-19 pandemic continues to spread, thousands of scientists around the globe
have changed research direction to understand better how the virus works and to find out how …

A promising approach to tackle the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
could be small interfering (si)RNAs. So far it is unclear, which viral replication steps …

The SARS‐CoV‐2 pandemic imposed a large burden on health and society. Therapeutics
targeting different components and processes of the viral infection replication cycle are being …

The SARS‐CoV‐2 infection cycle is a multistage process that relies on functional interactions
between the host and the pathogen. Here, we repurposed antiviral drugs against both viral …

The cell intrinsic antiviral response of multicellular organisms developed over millions of
years and critically relies on the ability to sense and eliminate viral nucleic acids. Here we use …

T cell immunity is crucial for control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection and has been studied widely on a quantitative level. However, the …

SARS-CoV-2 enters host cells after binding through its spike glycoprotein to the angiotensin-converting
enzyme 2 (ACE2) receptor. Soluble ACE2 ectodomains bind and neutralize the …

Dear Editor, CRISPR/Cas13 systems are programmable tools for manipulating RNAs and
are used in a variety of RNA-targeting applications 1–3. Within the Cas13 family, Cas13d is …